Assisted Reproductive Technology (ART) Market 2023 Top Key Player Analysis – Irvine Scientific, Origio a/s, Vitro Life, Esco Micro Pte. Ltd., IVFtech ApS, Cook Medical

This global Assisted Reproductive Technology (ART) market report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for historical data as well as provides forecasts for next few years.

Global Assisted Reproductive Technology Market size is expected to reach USD 31.4 billion by 2023; as per a new research report. Key driving factors include increasing prevalence of infertility owing to increase sedentary lifestyle, obesity, and stress.

Frozen nondonor procedures accounted for USD 4.9 billion in 2015, and is expected to exhibit a significant growth up to 2023. As reported by U.S. CDC in 2012, 97% women younger than age 35 used their own eggs (nondonor) while about 3% of women used donor eggs. Delayed parenthood decisions and increased patient awareness about advanced contraceptives and adoption of ART services expected to boost assisted reproductive technology market.
According to WHO, one in every four couples in developing countries have been found to be infertile and overall infertility prevalence in women has remained similar from 1990 to 2010. As reported by U.S. CDC, infertility prevalence rate is 10.9% in 2010. ART industry is also projected to witness substantial growth due to cultural shift of infertile patients towards advanced procedures such as IVF, ICSI, GIFT, ZIFT.

As per the Society of Human Reproduction and Embryology, Europe assisted reproductive technology market size is approximately 55% of all reported ART cycles. Over 600,000 cycles were reported from 33 EU countries in 2014. Regulatory trends, particularly in Europe and the U.S. will play a critical role in industry evolution and penetration.

U.S. assisted reproductive technology market share accounted for 95% of total North America revenue in 2015. Advanced healthcare facilities in and education among the patients enables propel demand.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467746/

Key insights from the report include:

Global assisted reproductive technology market size generated revenue of USD 22.3 billion in 2015.

North America is driven by favorable reimbursement policies on advanced ART procedures and high infertility prevalence.

Asia Pacific is expected to witness lucrative growth over the forecast period due to increase in disposable income, increase in the health care infrastructure. APAC is led by Japan, China, India. Japan assisted reproductive technology market, accounting for more than 45% of sales revenue in 2015.

Increasing infertility prevalence is a key driver for Europe, led by UK, Germany, France, Italy and Spain. Germany reproductive technology market size was responsible for over 28% of regional sales in 2015, with more than 5% growth anticipated by 2023.

Brazil reproductive technology market share was USD 0.62 billion in 2015, which is set to continue being the fastest growing industry in LATAM.
Key industry players include Irvine Scientific, Origio a/s, Vitro Life, Esco Micro Pte. Ltd., IVFtech ApS, Cook Medical, Research Instruments, Genea Limited, Smiths Medical, Thermo Fisher Scientific, Inc. etc.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467746/

Selected points from Table of Contents of this report:

Chapter 3. Assisted Reproductive Technology (ART) Industry Insights
3.1. Industry segmentation
3.2. Industry size and forecast, 2012 - 2023
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rise in the infertility prevalence
3.3.1.2. Demographical (Cultural) shift
3.3.1.3. Regulatory Environment
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of ART procedures
3.3.2.2. Lack of advanced technologies
3.4. Growth potential analysis
3.5. Porter's analysis
3.6. Competitive landscape, 2015
3.7. PESTEL analysis
Chapter 4. Assisted Reproductive Technology (ART) Procedure Insights
4.1. Assisted Reproductive Technology (ART) market share by procedure, 2015 & 2023
4.2. Fresh Donor
4.2.1. Market estimates and forecast, 2012-2023 (USD Million)
4.2.2. Market estimates and forecast, by region 2012-2023 (USD Million)
4.3. Fresh Nondonor
4.3.1. Market estimates and forecast, 2012-2023 (USD Million)
4.3.2. Market estimates and forecast, by region 2012-2023 (USD Million)
4.4. Frozen Donor
4.4.1. Market estimates and forecast, 2012-2023 (USD Million)
4.4.2. Market estimates and forecast, by region 2012-2023 (USD Million)
4.5. Frozen Nondonor
4.5.1. Market estimates and forecast, 2012-2023 (USD Million)
4.5.2. Market estimates and forecast, by region 2012-2023 (USD Million)
4.6. Egg bank/Embryo bank
4.6.1. Market estimates and forecast, 2012-2023 (USD Million)
4.6.2. Market estimates and forecast, by region 2012-2023 (USD Million)
Chapter 5. Assisted Reproductive Technology (ART) Regional Insights
5.1. Assisted Reproductive Technology (ART) market share by region, 2015 & 2023
5.2. North America
5.2.1. Market estimates and forecasts, 2012 - 2023 (USD Million)
5.2.2. Market estimates and forecasts by procedure, 2012 - 2023 (USD Million)
5.2.3. U.S.
5.2.3.1. Market estimates and forecasts, 2012 - 2023 (USD Million)
5.2.3.2. Market estimates and forecasts by procedure, 2012 - 2023 (USD Million)
5.2.4. Canada
5.2.4.1. Market estimates and forecasts, 2012 - 2023 (USD Million)
5.2.4.2. Market estimates and forecasts by procedure, 2012 - 2023 (USD Million)

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Web site: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.